by TrN2016_SandWich | Apr 12, 2016
Charles Phillips Charles has extensive experience in medical leadership of face to face meetings with regulators in the US, UK, Canada and Australia. Providing the clinical overview for registration filings of a biologic product, Type II variations on existing...
by TrN2016_SandWich | Apr 12, 2016
Janet Worrell Janet is a pharmacist with a PhD in medicinal chemistry, alumni Manchester and Strathclyde respectively. She has worked in Regulatory Affairs supporting drug development from scientific advice through early phase development (clinical & technical) to...
by TrN2016_SandWich | Apr 12, 2016
Rob Wallis 30 years of drug discovery and development expertise working with project teams operating from target selection to post-marketing. Expert in Safety Pharmacology, including the implementation of ICHS7A and ICH 7B strategies and the application of safety...
by TrN2016_SandWich | Apr 12, 2016
Cynthia Davenport Cynthia J. Davenport, Ph.D., has provided professional toxicology services to the pharmaceutical industry as an independent consultant since 2007. With more than 20 years of pharmaceutical industry experience, Dr. Davenport provides subject-matter...
by TrN2016_SandWich | Apr 12, 2016
Jaminder Khinder A highly experienced Drug Development Scientist with 25 years experience in nonclinical drug safety and nonclinical regulatory for small molecules and biotherapeutics at GlaxosmithKline and Pfizer. Expertise in nonclinical project lead roles with...
